The Inflation Reduction Act was signed into law on August 16, 2022, and the debate over its Medicare-related benefits and impact on the prescription drug market has been raging ever since.Among the financial benefit tenets of the Inflation Reduction Act (IRA) as they relate to the medical field and Medicare are that it lowers prescription […]
